Adherencia y satisfacción en la profilaxis antitrombótica ambulatoria oral frente a la parenteral: estudio SALTO
- 1 January 2013
- journal article
- clinical trial
- Published by Elsevier in Revista Española de Cirugía Ortopédica y Traumatología
- Vol. 57 (1) , 53-60
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Dabigatran, Rivaroxaban and Apixaban versus Enoxaparin for thomboprophylaxis after total knee or hip arthroplasty: Pool-analysis of phase III randomized clinical trialsThrombosis Research, 2012
- Therapeutic potential of apixaban in the prevention of venous thromboembolism in patients undergoing total knee replacement surgeryJournal of Thrombosis and Thrombolysis, 2012
- Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trialThe Lancet, 2008
- Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip ArthroplastyNew England Journal of Medicine, 2008
- Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee ArthroplastyNew England Journal of Medicine, 2008
- Venous thromboembolism (VTE) in EuropeThrombosis and Haemostasis, 2007
- Prevention of Venous ThromboembolismChest, 2004
- Compliance with Self-Administration of Heparin Injections in OutpatientsEuropean Journal of Trauma, 2002
- A Meta-Analysis of Thromboembolic Prophylaxis Following Elective Total Hip Arthroplasty*Journal of Bone and Joint Surgery, 2000
- Concurrent and Predictive Validity of a Self-reported Measure of Medication AdherenceMedical Care, 1986